Discovering KRT31: A Potential Drug Target for Neurological Disorders

Target Name: KRT31

NCBI ID: G3881

KRT31

Discovering KRT31: A Potential Drug Target for Neurological Disorders

KRT31, also known as Ha-1, is a protein that is expressed in the human brain and is involved in the formation of new blood vessels. The discovery of KRT31 as a potential drug target has significant implications for the treatment of various neurological disorders.

KRT31 is a transmembrane protein that is expressed in the brain, heart, and kidneys. It is a key regulator of blood vessel formation and has been shown to play a role in the development and maintenance of new blood vessels. KRT31 has been shown to be expressed in the endothelial cells, which are the cells that line the blood vessels, and it is thought to regulate the formation of new endothelial cells.

One of the key functions of KRT31 is its role in the regulation of angiogenesis, which is the process by which new blood vessels are formed. KRT31 has been shown to be involved in the regulation of angiogenesis by promoting the migration of blood vessels and by regulating the proliferation of endothelial cells.

In addition to its role in blood vessel formation, KRT31 has also been shown to be involved in the regulation of cell signaling pathways that are important for brain development and function. For example, KRT31 has been shown to be involved in the regulation of theNotch signaling pathway, which is important for the development and function of the nervous system.

The Notch signaling pathway is a protein that is involved in the regulation of cell signaling pathways that are important for brain development and function. It is thought to play a key role in the development of neural stem cells, which are the cells that give rise to all of the different cell types in the nervous system.

KRT31 has also been shown to be involved in the regulation of the TGF-β signaling pathway, which is important for the development and maintenance of blood vessels. TGF-β is a protein that is involved in the regulation of cell signaling pathways, including those that are important for blood vessel formation.

In conclusion, the discovery of KRT31 as a potential drug target has significant implications for the treatment of various neurological disorders. Further research is needed to fully understand the role of KRT31 in the regulation of blood vessel formation and cell signaling pathways, and to develop effective treatments for the disorders that are caused by these processes.

Protein Name: Keratin 31

The "KRT31 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRT31 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets